Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03350906 · ClinicalTrials.gov registry record · Phase 3
Enhancing Adaptations to Exercise
A Phase 3 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 63
- Enrollment target
NCT03350906: Completed Phase 3 study, sponsored by Mayo Clinic.
NCT03350906 is a Phase 3 study that has completed, run by Mayo Clinic. The registered enrollment target is 63 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03350906, a Phase 3 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 63 participants
- Enrollment target
Study Summary
Researchers are trying to understand how chronic inflammation affects muscle function and responses to exercise.They are also trying to determine if suppressing chronic inflammation using omega-3 fatty acids (n3-PUFA) restores skeletal muscle function and exercise responsiveness in older adults.
Interventions
- DRUG Placebo
- PROCEDURE Biopsy
- DRUG n3-PUFA
- DIAGNOSTIC_TEST Body Composition Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2021-12-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03350906
The ClinicalTrials.gov registry entry for NCT03350906 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT03350906 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03350906 about?
NCT03350906 is a clinical study titled "Enhancing Adaptations to Exercise". Researchers are trying to understand how chronic inflammation affects muscle function and responses to exercise.They are also trying to determine if suppressing chronic inflammation using omega-3 fatty acids (n3-PUFA) restores skeletal muscle function and exercise responsiveness in older adults.
What is the current status of trial NCT03350906?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 63 participants. The study started on 2018-01-01. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT03350906?
The interventions under investigation include: Placebo (DRUG), Biopsy (PROCEDURE), n3-PUFA (DRUG), Body Composition Scan (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03350906?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.